BAM66519 PF-04217903   PF-04217903 is a MET inhibitor with an IC50 from 3.1 nM to142 nM. Quantity Price 10 mg 160.00 50 mg 550.00 100 mg 950.00 200 mg 1500.00                 C19H16N8O   98+% MFCD12407410

BAM66390 XL184 XL184 (Cabozantinib) is a potent multitargeted VEGFR2, Met, FLT3, Tie2, Kit and Ret inhibitor with IC50 of 0.035, 1.8, 14.4, 14.3 and 4.6 nM for VEGFR2, Met, FLT3, Tie2 and Kit, respectively. Quantity Price 10 mg 120.00 50 mg 470.00 200 mg 1470.00                     C28H24FN3O5 849217-68-1 98+% MFCD17010276

BAM66390 Cabozantinib XL184 (Cabozantinib) is a potent multitargeted VEGFR2, Met, FLT3, Tie2, Kit and Ret inhibitor with IC50 of 0.035, 1.8, 14.4, 14.3 and 4.6 nM for VEGFR2, Met, FLT3, Tie2 and Kit, respectively. Quantity Price 10 mg 120.00 50 mg 470.00 200 mg 1470.00                     C28H24FN3O5 849217-68-1 98+% MFCD17010276

BAM66390 BMS-907351 XL184 (Cabozantinib) is a potent multitargeted VEGFR2, Met, FLT3, Tie2, Kit and Ret inhibitor with IC50 of 0.035, 1.8, 14.4, 14.3 and 4.6 nM for VEGFR2, Met, FLT3, Tie2 and Kit, respectively. Quantity Price 10 mg 120.00 50 mg 470.00 200 mg 1470.00                     C28H24FN3O5 849217-68-1 98+% MFCD17010276

BAM66412 EMD1214063 A potent, selective and orally bioavailable c-Met inhibitor, currently in clinical trial. Quantity Price 5 mg 150.00 10 mg 250.00 50 mg 750.00 100 mg 1250.00                 C29H28N6O2 1100598-32-0 96+% MFCD18452823